news
Bristol-Myers Squibb expands R&D presence in the US
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
List view / Grid view
Hit-to-Lead
news
ViraTherapeutics raises €3.6 million to advance its lead product VSV-GP
24 June 2015 | By Victoria White
ViraTherapeutics has announced the first closing of a Series A financing round, raising €3.6 million that it will use to advance its lead product VSV-GP...
news
Novogen’s Anisina on track to enter the clinic in 2016
24 June 2015 | By Victoria White
Novogen has announced that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals...
news
AYOXXA and Grünenthal complete research collaboration
24 June 2015 | By Victoria White
AYOXXA and Grünenthal have completed a research collaboration to validate detection limits for a biomarker based on AYOXXA’s proprietary technology platform...
news
Blueprint Medicines announces first preclinical data for BLU6864
23 June 2015 | By Victoria White
Blueprint Medicines has announced the first preclinical data for its drug candidate BLU6864, a RET-specific kinase inhibitor.
video
The Science of Affimers
Find out about the science behind Affimers - including why Affimers are superior to antibodies and details about our custom Affimer process...
video
Affimers and Therapeutic Applications
Find out more about the applications of Affimers, including how Affimers can be used in the development of therapeutics...
news
PSMA-617 can be used to irradiate prostate cancer cells from the inside
22 June 2015 | By Victoria White
Scientists at the German Cancer Research Centre have developed an agent, PSMA-617, which is capable of attaching specifically to prostate cancer cells...
news
Brain inflammation targeted in first Dementia Consortium drug discovery project
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
video
An Introduction to Avacta Life Sciences
This video introduces Avacta Life Sciences, part of Avacta Group plc and its flagship product, Affimers - a revolutionary new, engineered alternative to antibodies...
news
SciFluor Life Sciences patented compound SF0034 highlighted in The Journal of Neuroscience
19 June 2015 | By SciFluor Life Sciences
SciFluor Life Sciences has announced that pre-clinical research demonstrating the potential effectiveness of its patented novel compound, SF0034, for treating epilepsy and preventing tinnitus was published in the peer-reviewed publication, The Journal of Neuroscience...
news
New biomarkers might help personalise metastatic colorectal cancer treatment
18 June 2015 | By Victoria White
New research has revealed two genes that could help physicians make more informed treatment decisions for patients with colorectal cancer...
news
Discovery could lead to targeted melanoma therapies
18 June 2015 | By Victoria White
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a new study...
news
ImmunoGen’s IMGN529 demonstrates synergistic activity with rituximab in preclinical models of non-hodgkin lymphoma
18 June 2015 | By Victoria White
Findings from ImmunoGen’s preclinical assessments of IMGN529 in combination with rituximab have been presented at ICML 2015...
news
GSK invests $95m to launch Altius with goal of radically changing and improving medicines development
17 June 2015 | By Victoria White
GSK is making a substantial investment to launch the Altius Institute for Biomedical Sciences (Altius), an independent, non-profit research institute...
